|
Ensuring access to vaccines and related products =>> Procurement/Supply of existing products =>>
Establish planning processes for vaccines provision, with focus on hepB, Hib and YF and support to other GAVI vaccine initiatives
Responsible entity: VPP
Completed by: December 2005
Total budget: $950,000
Target description and how it will help reach GAVI milestones
Information on country demand, product preference and future needs is to be shared with industry early in the years, since lead times in the vaccine industry, whether for product development, capacity investment or production, are relatively long. VPP team aims to produce accurate, product- specific, long-term forecast (for hepB, Hib, YF and any other new vaccine supported by GAVI) that enhances the credibility of demand and commands sufficient confidence amongst partners to allow the majority of GAVI’s vaccine to be procured on a firm contract basis. A failure of VPP to give early indication of vaccine demand and availability would result in delay in introduction of new vaccines and ultimately in preventing children deaths.
HepB & Hib MILESTONES: An accurate, product-specific, long-term forecast (for hepB, Hib, YF and any other new vaccine supported by GAVI) will enhance the credibility of demand and will command sufficient confidence amongst partners to avail sufficient vaccines to meet country
Justification for selection of activities
In order to develop a long-term plan for provision of vaccines it is essential that:
- WHO expands the mechanisms for vaccine pre-qualification;
- UNICEF SD prepares the strategy for developing the 2007-09 procurement plan; the
- VF shares information on increasing funding to cover the new vaccines requirements for 2005-15.
- The Secretariat shares information on long term country plans for co-funding immunization.
ACTION PLAN
| Activities |
Budget |
Coordinating partner/ support partners |
Expected outcomes |
| Quantify product demand and quality of product |
$450,000 |
WHO |
• Demand of vaccines is forecasted for medium and long-term period and quality of products is pre-qualified in a prioritized fashion for hepB, Hib, YF and for other vaccines according to GAVI priorities for new vaccines introduction. |
| Analyze vaccines availability and market conditions |
$500,000 |
UNICEF |
• Medium and long-term provision of vaccines to countries is planned for hepB, Hib, YF vaccines and for other vaccines according to GAVI priorities for new vaccines introduction. |
| Assess actual and potential VF funding level |
$0 |
VF |
• VF funding is programmed for medium and long-term procurement of hepB, Hib, YF vaccines and for other GAVI vaccines priorities |
| Assess actual and potential country funding level |
$0 |
Secretariat VF UNICEF |
• Countries funding is programmed for medium and long-term procurement of hepB, Hib, YF vaccines and for other GAVI vaccines priorities |
Detailed information on activities
Activity 1:
Budget: $ 225,000 to strengthen National Regulatory Authorities for each year. Nine training courses for National Regulatory Authorities to be organized in AEFI surveillance (3), GMP inspection (1), clinical evaluation(1), regulation of vaccines (1), lot release (1), laboratory quality systems (1) and quality control of DTP vaccines (1).
Activity 2:
Budget: The budget for UNICEF activities is $ 250,000 each year for travel and technical assistance, funded from other sources.
Activity 3:
Budget: The cost of the VF's staff time has not been included in the budget
Activity 4:
Partners: UNICEF-SD and the VF, for annual exchange of information on updated multi-year country plan for internal funding of immunization programme. The main sources of information will be the annual reviews of Progress Reports and of Financial Sustainability Plans. |
|
|
|
Targets by priority area
Ensuring access to vaccines and related products
==>> Procurement/Supply of existing products
• Minimal divergence between vaccine forecasts and uptake.
• Establish planning processes for vaccines provision, with focus on hepB, Hib and YF and support to other GAVI vaccine initiatives
==>> Development and introduction of new, near-term products
==>> Managing process for country support from Vaccine Fund
Securing long-term financing
==>> Financial sutainability
==>> Recapitalization of The Vaccine Fund
Strategic planning & monitoring
==>> Setting priorities
==>> Monitoring progress
Other
==>> Alliance coordination
Strengthening service delivery
==>> Health information and monitoring systems
==>> Contributing to alleviation of system-wide barriers
==>> Enhanced efforts in large population countries |
|